Track the Hemostemix Inc. share price and the full management transaction log of the company, a listed equity based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €14.8m. The latest transaction was filed on 10 August 2026 (11 - Acquisition or disposition carried out privately). Among the most active insiders: Swanberg, Loran Lavern. The full history is accessible without an account.
22
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
46Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
100,000 shares@ CA$0.152.7% of flowWarrantsTSXSEDI:4550455
22 of 22 declarations
Acerca de Hemostemix Inc.
Hemostemix Inc. es una empresa que cotiza en la Bolsa de Valores de Toronto, centrada en el desarrollo de terapias regenerativas para enfermedades cardiovasculares. Utiliza tecnologías basadas en células madre para mejorar la salud de los pacientes.